Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06388889
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-29
First Post:
2024-03-27
Brief Title:
Phase III Long-Term Extension Study With Dexpramipexole
Sponsor:
Areteia Therapeutics
Organization:
Areteia Therapeutics
Organization Data
Organization:
Areteia Therapeutics
Class:
INDUSTRY
Study ID:
AR-DEX-22-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Areteia Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None